DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $3,971,000 | +9.3% | 42,779 | +1.0% | 2.25% | +2.2% |
| Q3 2017 | $3,632,000 | +1.4% | 42,346 | -0.2% | 2.21% | +2.1% |
| Q2 2017 | $3,582,000 | -2.0% | 42,448 | -0.7% | 2.16% | -2.3% |
| Q1 2017 | $3,656,000 | +4.8% | 42,748 | -4.6% | 2.21% | +16.7% |
| Q4 2016 | $3,487,000 | -3.1% | 44,797 | -2.4% | 1.89% | +35.0% |
| Q3 2016 | $3,599,000 | -25.1% | 45,914 | -3.5% | 1.40% | -20.1% |
| Q2 2016 | $4,806,000 | +4.0% | 47,584 | -2.3% | 1.76% | +7.2% |
| Q1 2016 | $4,621,000 | -0.7% | 48,712 | -2.8% | 1.64% | +12.8% |
| Q4 2015 | $4,653,000 | +8.4% | 50,098 | -0.5% | 1.45% | +1.3% |
| Q3 2015 | $4,292,000 | +11.9% | 50,366 | +12.4% | 1.43% | +16.5% |
| Q2 2015 | $3,836,000 | -14.0% | 44,818 | -14.7% | 1.23% | -8.1% |
| Q1 2015 | $4,463,000 | -10.7% | 52,568 | -9.8% | 1.34% | -9.2% |
| Q4 2014 | $4,996,000 | +12.5% | 58,295 | -0.2% | 1.47% | +12.3% |
| Q3 2014 | $4,439,000 | -25.2% | 58,419 | -22.5% | 1.31% | -32.9% |
| Q2 2014 | $5,936,000 | -0.5% | 75,387 | -0.7% | 1.96% | -6.9% |
| Q1 2014 | $5,963,000 | +0.6% | 75,902 | -1.1% | 2.10% | +2.4% |
| Q4 2013 | $5,927,000 | – | 76,774 | – | 2.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |